HIV And Parasitic Infection (HAPI) Study

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

August 4, 2023

Study Completion Date

August 4, 2023

Conditions
HIV Coinfection
Interventions
DRUG

Antiparasitic medication

"Participants in the parasite-positive group (based on positive result of either stool microscopy or stool PCR) will be administered antiparasitic treatment. Antiparasitic medication administered will be targeted to treat the parasite identified. See detailed description of protocol for medication, dose, and frequency that will be given for each parasitic infection identified.~Participants with negative stool microscopy and negative stool PCR will not be administered treatment, thus will serve as controls."

Trial Locations (1)

Unknown

Lighthouse Clinic, Lilongwe

All Listed Sponsors
collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

University of North Carolina, Chapel Hill

OTHER